Biotoxtech Co., Ltd. (KOSDAQ:086040)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,445.00
+50.00 (2.09%)
At close: Jun 18, 2026

Biotoxtech Revenue

Biotoxtech had revenue of 11.87B KRW in the quarter ending March 31, 2026, with 5.51% growth. This brings the company's revenue in the last twelve months to 47.64B, up 9.26% year-over-year. In the year 2025, Biotoxtech had annual revenue of 47.02B with 13.73% growth.

Revenue (ttm)
47.64B
Revenue Growth
+9.26%
P/S Ratio
0.81
Revenue / Employee
253.38M
Employees
188
Market Cap
38.44B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202547.02B5.68B13.73%
Dec 31, 202441.34B8.71B26.69%
Dec 31, 202332.63B-4.66B-12.50%
Dec 31, 202237.29B4.57B13.98%
Dec 31, 202132.72B6.29B23.80%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
S Connect Co., LTD.253.43B
Green Plus115.20B
Carelabs Co.,Ltd79.17B
TKG Aikang70.50B
Milae Bioresources69.89B
KD Chem64.11B
Korean Drug62.76B
Dexter Studios51.01B
Revenue Rankings